Citations

Showing 10 of 108152 citations.

Editorial Comment: Shift in Rectal Cancer Treatment Strategies
Bolan, Candice W.

Mayo Clinic

American Journal of Roentgenology | May 26, 2021 | Volume: 217 | Issue: 6 | Pages: 1294-1294

10.2214/ajr.21.26213 | PMID 34037414 Get It

Sinusoidal endotheliopathy in nonalcoholic steatohepatitis: therapeutic implications
Ibrahim, Samar H. , Ibrahim, Samar H

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | May 26, 2021 | Volume: 321 | Issue: 1 | Pages: G67-G74

10.1152/ajpgi.00009.2021 | PMID 34037463 Get It

Liver sinusoidal endothelial cells (LSECs) are distinct subtypes of endothelial cells lining a low flow vascular bed at the interface of the liver parenchyma and the circulating immune cells and soluble factors. Emerging literature implicates LSEC in the pathogenesis and progression of nonalcoholic fatty liver disease (NAFLD). During the evolution of NAFLD, LSEC dysfunction ensues. LSECs undergo morphological and functional transformation known as “capillarization,” as well as a pathogenic increase in surface adhesion molecules expression, referred to in this review as “endotheliopathy.” LSECs govern the composition of hepatic immune cell populations in nonalcoholic steatohepatis (NASH) by mediating leukocyte subset adhesion through specific combinations of activated adhesion molecules and secreted chemokines. Moreover, extracellular vesicles released by hepatocyte under lipotoxic stress in NASH act as a catalyst for the inflammatory response and promote immune cell chemotaxis and adhesion. In the current review, we highlight leukocyte adhesion to LSEC as an initiating event in the sterile inflammatory response in NASH. We discuss preclinical studies targeting immune cells adhesion in NASH mouse models and potential therapeutic anti-inflammatory strategies for human NASH.
Cerebral malaria with extensive subcortical microhemorrhages
Zahid, Anza , Mark, Ian T. , Gilbertson, Julie R., Mark, Ian , Johnson, Derek R.

Mayo Clinic

Oxford Medical Case Reports | May 26, 2021 | Volume: 2021 | Issue: 5 | Pages: No page available

10.1093/omcr/omab028 | PMID 34055364 Get It

Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions
Sorce, Gabriele , Motterle, Giovanni , Cucchiara, Vito , Gandaglia, Giorgio , Montorsi, Francesco , Karnes, R. Jeffrey , Guccini, Ilaria , Briganti, Alberto , Larcher, Alessandro , Stabile, Armando , Montorsi, Francesco , Guccini, Ilaria , Stabile, Armando , Lucianò, Roberta , Scuderi, Simone , Barletta, Francesco Maria , Pellegrino, Francesco , Fossati, Nicola , COBELLI, Francesco DE

Mayo Clinic

BJU International | May 26, 2021 | Volume: 129 | Issue: 2 | Pages: 201-207

10.1111/bju.15498 | PMID 34038039 Get It

Objective To assess the relationship between the volume of the index lesion (IL) measured at multiparametric magnetic resonance imaging (mpMRI; MRIvol) and at radical prostatectomy (RPvol), stratifying it according to Prostate Imaging‐Reporting and Data System (PI‐RADS) score. Patients and Methods We identified 332 men with a positive mpMRI (single lesion with PI‐RADS ≥3) who underwent systematic plus targeted biopsy and subsequent RP at two tertiary referral centres between 2013 and 2018. All mpMRIs were reviewed by experienced radiologists using PI‐RADS scores. The study outcome was to assess the relationship between MRIvol (based on planimetry from MRI sequence best showing tumour) and RPvol (based on tumour involved area of each RP pathology slice). To achieve this endpoint, we performed a multivariable linear regression analysis (LRA) to predict RPvol using PI‐RADS, prostate‐specific antigen level, prostate volume, age, digital rectal examination, Gleason score at MRI‐targeted biopsy, biopsy history and time from mpMRI to RP as covariates. Non‐parametric locally estimated scatterplot smoothing (LOESS) function was used to graphically explore the relationship between MRIvol and RPvol, stratifying for PI‐RADS score. Results Overall, 24%, 49% and 27% of men had visible PI‐RADS 3, 4 and 5 lesions at mpMRI. The median (interquartile range [IQR]) MRIvol and RPvol were 0.67 (0.29–1.76) mL and 1.39 (0.58–4.23) mL. At LRA, MRIvol was significantly correlated with a RPvol underestimation (slope: 2.4, 95% confidence interval [CI] 0.1–46.3). The non‐parametric LOESS analysis showed a non‐linear relationship between MRIvol and RPvol. Significant underestimation was reported across all volumes with the highest differences between MRIvol and RPvol in the low volume range (<2 mL), where RPvol almost doubled MRIvol. A similar effect was observed across all PI‐RADS scores subgroups. Conclusions In the present study, mpMRI significantly underestimated the exact volume of the IL, especially for small visible lesions, regardless of PI‐RADS score. This should be considered when planning tailored focal therapy approaches often delivered to men with smaller prostatic lesions.
Use of convalescent plasma inCOVID‐19 patients with immunosuppression
Senefeld, Jonathon W. , Klassen, Stephen A. , Ford, Shane , Senese, Katherine A. , Wiggins, Chad C. , Bostrom, Bruce , Nicholson, Wayne T. , Carter, Rickey E. , Hartman, William R. , Pirofski, Liise‐anne , Wright, R. Scott , Fairweather, De Lisa, Bruno, Katelyn A. , Joyner, Michael J. , Fairweather, DeLisa , Ford, Shane K, Hartman, William R , Fairweather, DeLisa , Carter, Rickey E , Wiggins, Chad C , Joyner, Michael J , Senefeld, Jonathon W , Klassen, Stephen A , Bruno, Katelyn A , Thompson, Michael A. , Baker, Sarah E. , Johnson, Patrick W. , Henderson, Jeffrey P. , Paneth, Nigel , Casadevall, Arturo

Mayo Clinic

Transfusion | May 26, 2021 | Volume: 61 | Issue: 8 | Pages: 2503-2511

10.1111/trf.16525 | PMID 34036587 Get It

AbstractIn the absence of effective countermeasures, human convalescent plasma has been widely used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel coronavirus disease 19 (COVID‐19), including among patients with innate or acquired immunosuppression. However, the association between COVID‐19‐associated mortality in patients with immunosuppression and therapeutic use of convalescent plasma is unknown. We review 75 reports, including one large matched‐control registry study of 143 COVID‐19 patients with hematological malignancies, and 51 case reports and 23 case series representing 238 COVID‐19 patients with immunosuppression. We review clinical features and treatment protocols of COVID‐19 patients with immunosuppression after treatment with human convalescent plasma. We also discuss the time course and clinical features of recovery. The available data from case reports and case series provide evidence suggesting a mortality benefit and rapid clinical improvement in patients with several forms of immunosuppression following COVID‐19 convalescent plasma transfusion. The utility of convalescent plasma or other forms of antibody therapy in immune‐deficient and immune‐suppressed patients with COVID‐19 warrants further investigation.
Preoperative embolization of jugular paraganglioma tumors using particles is safe and effective
Helal, Ahmed , Vakharia, Kunal , Brinjikji, Waleed , Carlson, Matthew L. , Driscoll, Colin L. W., Link, Michael J., Cloft, Harry J. , Driscoll, Colin LW, Cloft, Harry, Gompel, Jamie J. Van , Link, Michael J.

Mayo Clinic

Interventional Neuroradiology | May 26, 2021 | Volume: 28 | Issue: 2 | Pages: 145-151

10.1177/15910199211019175 | PMID 34034540 Get It

Background Jugular paragangliomas represent a surgical challenge due to their vascularity and proximity to vital neurovascular structures. Preoperative embolization aids in reducing intraoperative blood loss, transfusion requirements, and improves surgical visualization. Several embolization agents have been used. Objective The aim of this study is to evaluate the safety and efficacy of PVA in pre-operative embolization of jugular paragangliomas. Methods A retrospective review of all patients who underwent jugular paraganglioma resection with pre-operative embolization between 2000 and 2020 was performed. Pre-operative data including baseline patient and tumor characteristics were documented. Outcomes of preoperative embolization including extent of devascularization and post-embolization complications were recorded. Early and long-term postoperative outcomes were reported. Results Twenty-nine patients met study criteria with a median age of 38 years. Average tumor size was 3.4±1.8 cm. The most commonly encountered arterial feeder was the ascending pharyngeal artery followed by the posterior auricular artery. More than 50% reduction in tumor blush was achieved in 25 patients (86.2%). None of the patients experienced new or worsening cranial neuropathy following embolization. Gross total or Near total resection was achieved in 13 patients (44.8%). A STR or NTR was chosen in these patients to preserve cranial nerve function or large vessel integrity. Average intraoperative estimated blood loss was 888 ml, 9 patients (31%) required intra-operative transfusion of blood products. Extent of resection and post-operative complications did not correlate with extent of devascularization. Conclusion Pre-operative embolization of jugular paraganglioma tumors with PVA particles is an effective strategy with a high safety profile.
Imaging features of Carney complex with external auditory canal myxoma
Abeer, Mousa A, Nguyen, Ba D. , Abeer, Mousa A

Mayo Clinic

Japanese Journal of Clinical Oncology | May 26, 2021 | Volume: 51 | Issue: 10 | Pages: 1595-1596

10.1093/jjco/hyab089 | PMID 34089059 Get It

Incidence and Characteristics of Kidney Stones in Patients on Ketogenic Diet: A Systematic Review and Meta-Analysis
Acharya, Prakrati , Acharya, Chirag , Hansrivijit, Panupong , Kanduri, Swetha Rani , Kovvuru, Karthik , Medaura, Juan , Vaitla, Pradeep , Anton, Desiree F. Garcia Garcia, Mekraksakit, Poemlarp , Pattharanitima, Pattharawin , Cheungpasitporn, Wisit , Hansrivijit, Panupong , Kanduri, Swetha R , Kovvuru, Karthik , Mekraksakit, Poemlarp , Pattharanitima, Pattharawin , Cheungpasitporn, Wisit , Thongprayoon, Charat

Mayo Clinic

Diseases | May 25, 2021 | Volume: 9 | Issue: 2 | Pages: 39

10.3390/diseases9020039 | PMID 34070285 Get It

Very-low-carbohydrate diets or ketogenic diets are frequently used for weight loss in adults and as a therapy for epilepsy in children. The incidence and characteristics of kidney stones in patients on ketogenic diets are not well studied. Methods: A systematic literature search was performed, using MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews from the databases’ inception through April 2020. Observational studies or clinical trials that provide data on the incidence and/or types of kidney stones in patients on ketogenic diets were included. We applied a random-effects model to estimate the incidence of kidney stones. Results: A total of 36 studies with 2795 patients on ketogenic diets were enrolled. The estimated pooled incidence of kidney stones was 5.9% (95% CI, 4.6–7.6%, I2 = 47%) in patients on ketogenic diets at a mean follow-up time of 3.7 +/− 2.9 years. Subgroup analyses demonstrated the estimated pooled incidence of kidney stones of 5.8% (95% CI, 4.4–7.5%, I2 = 49%) in children and 7.9% (95% CI, 2.8–20.1%, I2 = 29%) in adults, respectively. Within reported studies, 48.7% (95% CI, 33.2–64.6%) of kidney stones were uric stones, 36.5% (95% CI, 10.6–73.6%) were calcium-based (CaOx/CaP) stones, and 27.8% (95% CI, 12.1–51.9%) were mixed uric acid and calcium-based stones, respectively. Conclusions: The estimated incidence of kidney stones in patients on ketogenic diets is 5.9%. Its incidence is approximately 5.8% in children and 7.9% in adults. Uric acid stones are the most prevalent kidney stones in patients on ketogenic diets followed by calcium-based stones. These findings may impact the prevention and clinical management of kidney stones in patients on ketogenic diets.
Risk of de novo severe carpal tunnel syndrome after bilateral oophorectomy: a population-based cohort study
Schrier, Verena J.M.M. , Song, Joanne, Rocca, Liliana Gazzuola , Amadio, Peter C. , Rocca, Walter A. , Starlinger, Julia , Gazzuola Rocca, Liliana, Smith, Carin Y. , Stewart, Elizabeth A.

Mayo Clinic

Menopause | May 25, 2021 | Volume: 28 | Issue: 9 | Pages: 1026-1036

10.1097/gme.0000000000001804 | PMID 34033605 Get It

Abstract Objective: The incidence of carpal tunnel syndrome (CTS) is higher in women, and peaks around the age of menopause. Therefore, we investigated whether bilateral oophorectomy is associated with an increased risk of severe CTS. Methods: We included all of the 1,653 premenopausal women who underwent bilateral oophorectomy for a nonmalignant indication between 1988 and 2007, and a random sample of 1,653 age-matched referent women who did not undergo bilateral oophorectomy in Olmsted County, MN. Diagnoses of CTS assigned to women over their entire lifetime were identified in these two cohorts. The risk of de novo severe CTS after bilateral oophorectomy (or index date) was evaluated using Cox proportional hazards models adjusted for potential confounders. Results: Bilateral oophorectomy was associated with an increased risk of severe CTS (adjusted hazard ratio 1.65, 95% confidence interval 1.20-2.25). The risk was suggestively greater in women with lower body mass index, nulliparity, and with a benign ovarian indication for oophorectomy (nonsignificant interactions). We did not observe a protective effect of estrogen therapy after the oophorectomy. The findings were similar in secondary analyses considering the incidence of CTS of any severity or idiopathic CTS. Conclusions: The risk of severe CTS, common in perimenopausal women, is increased after bilateral oophorectomy. The association may be causal or due to confounding. Therefore, the precise biological mechanisms explaining the association and the absence of a mitigating effect of estrogen therapy should be further investigated.